LANXESS worldwide

Corporate Website en | de


  • Australia en

  • China cn | en

  • India en

  • Indonesia en

  • Japan jp

  • Korea kr

  • Malaysia en

  • Pakistan en

  • Philippines en

  • Singapore en

  • Thailand en

  • Vietnam en


  • Austria en

  • Belgium nl

  • Czech en

  • France fr

  • Hungary en

  • Italy en

  • Netherlands en

  • Poland en

  • Russia ru | en

  • Serbia en

  • Slovakia en

  • Spain en

  • Turkey en

  • United Arab Emirates en

  • United Kingdom en




Using Saltidin® (Picaridin/Icaridin) to Guard Against Insect-borne Diseases

  • Insect repellents with the active ingredient Saltidin® (Picaridin/Icaridin) from LANXESS provide effective, pleasant protection

Pittsburgh, PA – February 19, 2018– Although much of the US is still experiencing winter, summer is just around the corner. And with the rise in temperatures comes an increase in the presence of biting insects.  Mosquitoes, ticks and other insects are not only a nuisance, they can spread dangerous diseases like the Zika virus and Lyme disease. 2017 was an extremely heavy tick season, and the U.S. Centers for Disease Control reports that 2016 was one of the worst years for Lyme Disease on record, with more than 35,000 cases in the United States. Insect repellents, including those containing Saltidin® (Picaridin/Icaridin), produced by LANXESS, offer proven protection again ticks and mosquitos.


The Zika virus remains a threat, as well.  According to the CDC, between January 1, 2015 and January 24, 2018 there were 5,646 reported cases of Zika virus disease (Zika) infection in the United States and another 37,158 in U.S. territories. Spread primarily through the bite of an infected mosquito, Zika currently has no specific medical treatment or vaccine, and infection during pregnancy has been linked to serious birth defects and neurological disorders. The CDC says the best way to prevent Zika is to protect against mosquito bites and recommends using an EPA-registered insect repellent. 


Saltidin® (Picaridin/Icaridin) is one of the CDC-recommended, EPA-registered insect repellent active ingredients found effective in preventing both Lyme disease and the Zika virus.


The highly effective, broad spectrum insect repellent active ingredient, Saltidin® (Picaridin/Icaridin) provides long-lasting, effective protection from mosquitoes, including those that carry and transmit Zika virus, as well as ticks.  Known for its skin-friendly properties, it is not oily, greasy or sticky on the skin. Another added benefit is that it does not damage plastics or other synthetic materials. 


“With the emergence of the Zika virus, protection from mosquitoes has become more important than ever, and Lyme disease seems to be a growing concern as well,” says Hans Essenbreis, business development manager for Saltidin®. “Consumers are becoming more conscious of what they put on their skin. So when they want effective protection without some of the disadvantages associated with traditional insect repellents, they turn to Saltidin® (Picaridin/Icaridin)-based repellents. As an active ingredient, Saltidin® offers formulators the perfect balance of effectiveness, safety and user-friendliness.” 


Developed in the 1990s and registered with the U.S. EPA since 2001, Saltidin® (Picaridin/Icaridin) is one of the newer EPA-registered insect repellent ingredients. It works by acting on insects’ odor receptors, disabling their ability to recognize humans as blood donors. Providing up to 14 hours of protection (depending on formulation), Saltidin® (Picaridin/Icaridin) is safe for children when used as directed and can be used with confidence on the whole family.  Currently, there are several major brands of Picaridin-based repellents available in the U.S. and throughout the world, in various concentrations and forms, such as sprays, creams, wipes and sticks.  Picaridin is recommended by the World Health Organization (WHO) for protection against mosquitoes carrying dengue fever and the Zika  virus.


For more information, including repellent brands containing Picaridin, visit 


Saltidin® is manufactured by LANXESS’ Saltigo business unit. Saltigo, a globally active company, is dedicated to custom synthesis and manufacturing services for small molecules. We serve globally the needs of customers in the Pharma, Agro, and Specialty Chemical industries. Our business consists of over 85% Custom Manufacturing Services; less than 15 % are multi customer products in niche areas. We provide cost effective services when and where our customers need them by applying excellent project management skills.


LANXESS is a leading specialty chemicals company with sales of EUR 7.7 billion in 2016 and about 19,200 employees in 25 countries. The company is currently represented at 74 production sites worldwide. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. Through ARLANXEO, the joint venture with Saudi Aramco, LANXESS is also a leading supplier of synthetic rubber. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World and Europe) and FTSE4Good.


Forward-Looking Statements This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accept any liability whatsoever arising directly or indirectly from the use of this document.


Information for editors:

All LANXESS news releases and their accompanying photos can be found at Recent photos of the Board of Management and other LANXESS image material are available at TV footage can be found at


You can find further information concerning LANXESS chemistry in our WebMagazine at


Follow us on Twitter, Facebook, Linkedin and YouTube:


Tim Gagne
Corporate Communications

Phone: +1 412-809-3723

send E-Mail